In this episode, Anne MacNeil discusses the highlights from day one of Bio 2025 in Boston with Troy and Melissa from Compliance Insight. They explore the significant attendance, the absence of the FDA, emerging trends in the biotech industry, regulatory challenges, and the increasing role of AI in biotech. The conversation also touches on networking opportunities and the engagement strategies employed at the conference.